Nanoparticles and Nanocarriers-Based Pharmaceutical Formulations 2022
DOI: 10.2174/9789815049787122010003
|View full text |Cite
|
Sign up to set email alerts
|

Introduction to Nanoparticles and Nanocarriers

Abstract: This chapter outlines the introduction of nanoparticles and nanocarriers, within which it delineates their classification into various categories of polymeric nanoparticles, metal nanoparticles, magnetic nanoparticles, inorganic nanocarriers, dendrimers, vesicular carriers, micelles, and a lot more, their synthesis techniques such as physical, chemical and biological, and their application in the medical sector. The chapter also focuses on various challenges faced by these nanocarrier systems in nanomedicine a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Liposomes are concentric phospholipid spheres with single (or multiple) bilayers made up of natural or synthetic lipids. 71,72 The cholesterol present in the liposomal structure increases the bilayer rigidity, hindering the encapsulated PS from permeating out. Furthermore, aer the liposomes reach systemic circulation, the lipid exchange between these nanocarriers and high-density lipids results in the disintegration of the liposomes which in turn causes a untimely release of PS in the circulation instead of the target tissue.…”
Section: Polymeric and Micellar Nanoparticlesmentioning
confidence: 99%
“…Liposomes are concentric phospholipid spheres with single (or multiple) bilayers made up of natural or synthetic lipids. 71,72 The cholesterol present in the liposomal structure increases the bilayer rigidity, hindering the encapsulated PS from permeating out. Furthermore, aer the liposomes reach systemic circulation, the lipid exchange between these nanocarriers and high-density lipids results in the disintegration of the liposomes which in turn causes a untimely release of PS in the circulation instead of the target tissue.…”
Section: Polymeric and Micellar Nanoparticlesmentioning
confidence: 99%